注射笔市场规模预计将从 2023 年的 427 亿美元增至 2031 年的 742 亿美元。预计 2023-2031 年市场复合年增长率为 7.14%。推动市场增长的主要因素是癌症、糖尿病、中风、心脏病和关节炎等慢性疾病患病率的上升以及战略发展的增加。然而,替代药物输送装置的存在和报销政策的不足限制了市场的增长。
注射笔市场分析
注射笔,也称为药物笔,是一种用于在皮下注射药物的装置。注射笔的设计目的是使注射治疗对患者来说更容易、更方便,旨在提高患者的依从性。考虑到注射所需的额外工作以及自我注射药物可能产生不良反应的可能性,这对于注射治疗来说尤其麻烦。
注射笔市场概况
一些普遍且昂贵的长期健康问题受到社会行为转变和人口老龄化的影响。世界卫生组织 (WHO) 预计,到 2026 年,57% 的人将患有慢性生活方式疾病。鉴于发展中国家人口预计将增加,新兴市场将受到尤其严重的打击。由于快速城市化,人们更有可能采取久坐的生活方式,这会导致肥胖和糖尿病。二十一世纪世界健康面临的主要问题之一是糖尿病。国际糖尿病联盟 (IDF) 估计,2019 年北美大约有 4600 万糖尿病患者,预计到 2045 年这一数字将增至 6200 万。
在预计的时间范围内,该疾病的患病率增加了近 35%。此外,许多慢性疾病,如多发性硬化症、骨质疏松症和心血管疾病,需要重复用药来控制疾病。世界卫生组织 (WHO) 报告称,心血管疾病每年导致超过 1790 万人死亡,使其成为主要原因。它正在成为全球大量患者群体注射给药的新规范。注射笔广泛应用于家庭医疗保健环境中,这有助于其市场增长。此外,大量患者可能在很少接受培训且没有医疗保健专家持续帮助的情况下使用它们。
定制研究以满足您的要求
我们可以优化和定制我们的标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
注射笔市场:
年均复合增长率(2023 - 2031)7.14%- 2023 年市场规模
427 亿美元 - 2031 年市场规模
742 亿美元
市场动态
- 慢性病患病率上升推动市场增长
- 各参与者的战略发展有利于市场增长
- 生物制品专利到期和生物仿制药的使用增加,产生了对注射笔的需求
关键人物;主力;重要一员
- 礼来公司
- 诺和诺德公司
- 欧文芒福德有限公司
- 赛诺菲公司
- 默克公司
- 哈塞尔迈尔有限公司
- 格雷斯海默股份公司
- 贝克顿迪金森公司
- 阿斯利康公司
- 梯瓦制药工业有限公司
区域概况
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
- 一次性注射笔和可重复使用注射笔
- 糖尿病
- 生长激素治疗
- 自身免疫性疾病
- 生育能力
- 癌症
- 其他疗法
- 医院和诊所
- 家庭护理
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
注射笔市场驱动因素和机遇
注射笔产品主要参与者采取战略增长发展有利于市场
多个市场参与者的存在是注射笔市场的一个决定性特征。市场参与者采用各种策略来扩大市场份额,包括新产品发布、区域增长和技术改进。由于越来越多地参与持续创新和技术进步,行业参与者开始更多地接受注射笔。知名公司进行研发投资以创造尖端技术并增加利润。
下面提到了与注射笔相关的一些关键发展:
- 2022年5月,FDA授权礼来公司的Mounjaro注射剂于2022年5月成为第一个也是唯一一个胰高血糖素样肽1(GLP-1)受体激动剂和葡萄糖依赖性促胰岛素多肽(GIP)注射剂,用于治疗成人2型糖尿病。 Mounjaro 有六种剂量:2.5 mg、5 mg、7.5 mg、10 mg、12.5 mg 和 15 mg。它采用礼来公司著名的自动注射笔包装,该注射笔已经连接了一根隐藏的针头。
- 2022 年 1 月,SHL Medical 与 Innovation Zed 联手提供联动笔式注射器解决方案。它推出了 InsulCheck DOSE,这是一种链接的附加小工具,可将传统的笔式注射器升级为智能工具,以协助跟踪治疗计划。
- 2021 年 11 月,为了提高一次性胰岛素笔连接附加组件的使用率,赛诺菲和罗氏在法国联手合作。合作伙伴将共同努力为药剂师和医生创建科学教育计划。
- 2021 年 9 月,诺和诺德 FlexTouch 胰岛素笔签署了关于 Mallya 智能传感器的新协议。进一步巩固BIOCORP与诺和诺德的合作。立即连接到诺和诺德 FlexTouch 胰岛素笔的是一个名为 Mallya 的智能传感器。使用 FlexTouch 笔的患者将能够使用 Mallya 记录和捕获每日胰岛素注射数据,包括胰岛素单位以及给药的日期和时间。该协议规定,诺和诺德将于 2023 年上半年开始在日本商业销售 Mallya。
因此,所有上述关键发展都在推动注射笔市场的增长。
生物制剂专利到期和生物仿制药的使用增加——注射笔市场的机遇
许多慢性疾病,包括糖尿病、多发性硬化症和癌症,正在用生物制剂治疗。这些药物本身就是独一无二的,制造和销售它们的公司获得了 20 年的专利保护。由于大多数专利已经过期或即将过期,其他市场参与者已开始推出生物仿制药或这些药物的自己的版本。
与原始生物制剂相比,生物仿制药——受到政府和保险公司青睐的低成本仿制药——近年来变得非常受欢迎。著名的市场参与者正在推动生物仿制药的采用,这进一步创造了对其给药注射笔的需求。根据 AJMC 的数据,截至 2022 年 12 月,美国共有 40 种生物仿制药获得批准,并有 25 种新的生物仿制药在美国上市。此外,由于反应迅速,注射剂得到了广泛使用,这增加了对注射笔安全性的需求。
此外,注射笔生产商不断提供如何正确使用注射笔的指导,以防止针刺伤和低血糖等并发症,预计这将进一步扩大注射笔的市场。例如,Aptar Pharma 旗下的 Noble 是医疗设备培训解决方案的全球领导者,该解决方案通过开发以患者为中心的给药培训设备(包括注射笔、自动注射器、预充式注射器等)来改善患者体验和结果。因此,生物仿制药的使用增加、专利到期以及药物注射剂的使用增加可能会在未来几年为注射笔市场的增长创造充足的机会。
注射笔市场报告细分分析
有助于推导注射笔市场分析的关键部分是类型、疗法和最终用户。
- 根据类型,注射笔市场分为一次性注射笔和可重复使用注射笔。 2023 年,一次性用品细分市场占有更高的市场份额。
- 根据治疗方法,市场分为糖尿病、生长、自身免疫性疾病、生育、激素治疗、癌症和其他治疗。
- 就最终用户而言,市场分为医院和诊所、家庭护理等
按地区划分的注射笔市场份额分析
注射笔市场报告的地理范围主要分为五个地区:北美、亚太地区、欧洲、中东和非洲、南美洲/中南美洲。
在北美,注射笔市场目前在预测年内正在经历指数级增长。 2023 年美国市场将主导全球注射笔市场 根据美国糖尿病协会的数据,2019 年有 3730 万美国人(占总人口的 11.3%)被诊断患有糖尿病。1 型糖尿病影响美国约 190 万人,即 244,000 人其中包括儿童和青少年。此外,每年有近 140 万美国人被诊断出患有糖尿病。美国疾病控制与预防中心估计,2020年美国有8800万成年人患有糖尿病前期,占成年人口的34.5%。耶鲁大学研究人员称,到 2022 年,近 3000 万美国人将患有糖尿病,其中约 700 万人需要每日注射胰岛素。
美国对不孕不育治疗的需求不断增加。例如,据美国疾病控制和预防中心 (CDC) 称,2019 年,美国 15 岁至 44 岁之间有 9% 的男性和 10% 的女性存在不孕问题。知名企业正在推出新颖的产品,以满足全球对注射笔不断增长的需求。例如,Merck KGaA 提供了一种预装的即用型注射笔,用于施用 GONAL-f 来治疗不孕症。因此,糖尿病和不孕不育问题病例的增加以及主要参与者推出的创新产品正在推动美国注射笔市场的发展。
注射笔市场报告范围
报告属性 | 细节 |
---|---|
2023年市场规模 | 427亿美元 |
2031 年市场规模 | 742亿美元 |
全球复合年增长率(2023 - 2031) | 7.14% |
历史数据 | 2021-2022 |
预测期 | 2024-2031 |
涵盖的细分市场 | 按类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
注射笔市场新闻和最新动态
注射笔市场是通过收集初级和二级研究后的定性和定量数据来评估的,其中包括重要的公司出版物、协会数据和数据库。以下是创新、业务扩展和战略市场发展的列表:
- 2022年5月,FDA批准礼来公司的Mounjaro注射液,这是第一个也是唯一一个GIP(葡萄糖依赖性促胰岛素多肽)和GLP-1(胰高血糖素样肽-1)受体激动剂,用于治疗成人2型糖尿病。 Mounjaro 将提供六种剂量(2.5 毫克、5 毫克、7.5 毫克、10 毫克、12.5 毫克、15 毫克),并采用礼来公司成熟的自动注射笔,带有预先连接的隐藏针头,患者无需使用需要处理或查看。 (来源:FDA)
注射笔市场报告范围和交付成果
《注射笔市场规模和预测(2021-2031)》报告对涵盖以下领域的市场进行了详细分析:
范围内涵盖的所有关键细分市场的全球、区域和国家层面的注射笔市场规模和预测
- 市场动态,例如驱动因素、限制因素和关键机遇
注射笔市场趋势
- 详细的 PEST/波特五力分析和 SWOT 分析
注射笔市场分析,涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
注射笔行业格局和竞争分析,包括市场集中度、热图分析、知名企业和最新发展
- 详细的公司简介
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
North America dominated the injection pen market in 2023
The rising prevalence of chronic disorders is the major factors fuelling the market growth of injection pens over the years.
Technological advancements and healthcare waste reduction are likely to remain a key trend in the market.
Eli Lilly and Co, Novo Nordisk AS, Owen Mumford Ltd., Sanofi SA, Merck KGaA, Haselmeier GmbH, Gerresheimer AG, Becton Dickinson and Co., AstraZeneca Plc, Teva Pharmaceutical Industries Ltd
The market is expected to register a CAGR of 7.14% during 2023–2031.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.